Patient-Driven Analgesic Protocol Selection for Post-Cesarean Pain Management

• Status: Completed
• Trial end date: 2017-05-22
• Target enrollment: 0
• Participant gender: Female

Summary

The ability to predict pain and then apply modified treatment protocols has been limited. Current practice is for physicians to select standard post-operative pain treatment protocols without patient consultation. This study hopes to determine if patient's involvement in analgesic drug/dosage selection can optimize pain relief while minimizing related side effects. This could result in a more patient-centered care model and individualized perioperative analgesic treatment protocols based on patient's preferences, needs and expectations.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Stanford University
• Treatments: Acetaminophen; Analgesics; Gabapentin; Ibuprofen; Morphine

Criteria

Inclusion Criteria:

• Women age 18-50

• Singleton gestation

• Not in active labor

• Scheduled for their 1st, 2nd, or 3rd elective Cesarean

• Cesarean deliveries under spinal or combined spinal epidural anesthesia (with no additional epidural doses administered)

Exclusion Criteria:

• History of chronic pain, anxiety, or depression

• Unable to understand the concept of Verbal Numerical Pain Scale at the time of informed consent

• Chronic consumption of opiates, antidepressants or anticonvulsants

• Intake of opioids, NSAIDS or acetaminophen 48hrs prior to the psychophysical test

• Preeclampsia (with any severe features)

• Diabetes (not controlled with diet and needing drugs)

• Preterm delivery (<35 weeks gestation)